Multiple Sclerosis Clinical Trial

Clinical Applications of Advanced Ophthalmic Imaging

Summary

The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls.

There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is an interventional phase which studies the changes in the eyes after taking an over-the-counter medical food (Ocufolin) for 6 months.

View Eligibility Criteria

Eligibility Criteria

Observational Phase 1 Group

Inclusion Criteria:

Self-reported normal healthy subjects;
Clinical diagnosis of Alzheimer's Disease, mild cognitive impairment, multiple sclerosis, dry eye, myopia, diabetics and stroke;
Who can keep the eye open for imaging.

Exclusion Criteria:

who can not read and sign the ICF;
who can not receiving ophthalmic imaging;
who cannot tolerate bright light during imaging.

Interventional Phase 2 Group:

Inclusion criteria

The participant will be eligible for entry in the study if s/he:

Is at least 18 years old and has full legal capacity to volunteer;
Has read and signed the IRB Informed Consent Document;
Is willing and able to follow participant instructions;
Has clear corneas and crystalline lens;
Initial visual acuities were 20/80 or better;
MTHFR C677TT homozygous, or MTHFR C677T/A1298C compound heterozygous with mild to moderate micro-aneurismal vascular retinopathy disease;
Hemoglobin A1c is 10 or less;
Normotensive with or without medications;
Without retinal capillary dropout or macular edema;
Blood homocysteine > 9.

Exclusion criteria

The subjects will be ineligible for entry into the study if s/he:

Has an active ocular disease;
Has had surgery or an eye injury within 6 months.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

5000

Study ID:

NCT03135327

Recruitment Status:

Recruiting

Sponsor:

University of Miami

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Bascom Palmer Eye Institute
Miami Florida, 33136, United States More Info
Jianhua Wang, MD, PHD
Contact
305-482-5010
[email protected]
Jianhua Wang, MD, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

5000

Study ID:

NCT03135327

Recruitment Status:

Recruiting

Sponsor:


University of Miami

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.